Should we still use iron dextran in hemodialysis patients?

被引：13

作者：

Hörl, WH ^{[1
]}

机构：

[1] Univ Hosp Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2001年 / 37卷 / 04期

关键词：

D O I：

10.1053/ajkd.2001.23761

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：859 / 861

页数：3

共 15 条

[1]

AUERBACH M, 1988, J LAB CLIN MED, V111, P566

[2] Parenteral iron use in the management of anemia in end-stage renal disease patients [J].

Bailie, GR ;

Johnson, CA ;

Mason, NA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :1-12

[3]

ESCHBACH JW, 2000, J AM SOC NEPHROL, V14, pA249

[4] Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans [J].

Faich, G ;

Strobos, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (03) :464-470

[5] The safety of intravenous iron dextran in hemodialysis patients [J].

Fishbane, S ;

Ungureanu, VD ;

Maesaka, JK ;

Kaupke, CJ ;

Lim, V ;

Wish, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) :529-534

[6] Suspected iron dextran-related adverse drug events in hemodialysis patients [J].

Fletes, R ;

Lazarus, JM ;

Gage, J ;

Chertow, GM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :743-749

[7] INTRAVENOUS IRON DEXTRAN IN CLINICAL MEDICINE [J].

HAMSTRA, RD ;

BLOCK, MH ;

SCHOCKET, AL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (17) :1726-1731

[8]

Hoigné R, 1998, SCHWEIZ MED WSCHR, V128, P528

[9]

Jayakumar S, 2000, DIALYSIS TRANSPLANT, V29, P198

[10] Intravenous administration of iron in epoetin-treated haemodialysis patients - which drugs, which regimen? [J].

Macdougall, IC .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (11) :1743-1745

← 1 2 →